caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1164775102

Isaac YeboahMD

PRACTICEMARSHFIELD CLINICSee all providers at this practice →
Hematology-OncologyMarshfield, WII
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (5)

CCN 520037
Hospital
CCN 520202
Hospital
CCN 520212
Hospital
CCN 521323
Hospital
CCN 521325
Hospital
REFERRAL NETWORK

Where Isaac Yeboah's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 2 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
ST JOSEPH'S HOSPITAL OF MARSHFIELD, INC1340
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
Marshfield Clinic Inc
Clinical Laboratory · Marshfield, WI
31182
ST JOSEPH'S HOSPITAL OF MARSHFIELD, INC1216
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
457
Unique beneficiaries
—
Total services
789
Distinct HCPCS
8
Medicare payment
$61K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 202 Hematology-Oncology providers in WI — top quintile (cohort median 680).
PRESCRIBING · PART D · 2024
Total Rx claims
626
Beneficiaries
—
Total drug cost
$992K
Distinct drugs
17
Brand share
12.6%
Top prescribed drugs
Anastrozole148 claims
Dexamethasone78 claims
Prochlorperazine Maleate51 claims
Hydroxyurea37 claims
Imatinib Mesylate35 claims
QUALITY · MIPS · 2024
Final MIPS score
80.6
Quality
55.5
Cost
71.5
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.23%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$18
Payment records
1
By payment type
Education$18